XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.24.3

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) $ in Thousands | Sep. 30, 2024 | Jun. 30, 2024 | Dec. 31, 2023 | Sep. 30, 2023 | Jun. 30, 2023 | Dec. 31, 2022
--- | --- | --- | --- | --- | --- | ---
Investments at cost |  | $ 733,232 |  | $ 759,182 |  |  |
Investments at fair value |  | 684,000 |  | 709,085 |  |  |
Medical Device Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 185,751 |  | 147,064 |  |  |
Investments at fair value |  | 179,092 |  | 145,019 |  |  |
Biotechnology Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 126,867 |  | 145,544 |  |  |
Investments at fair value |  | 106,865 |  | 117,781 |  |  |
Software Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 136,309 |  | 164,133 |  |  |
Investments at fair value |  | 132,951 |  | 160,749 |  |  |
Communications Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 13,577 |  | 19,192 |  |  |
Investments at fair value |  | 15,596 |  | 22,188 |  |  |
Diagnostics Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 16,692 |  | 19,735 |  |  |
Investments at fair value |  | 14,114 |  | 19,701 |  |  |
Other Sustainability Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 66,501 |  | 98,906 |  |  |
Investments at fair value |  | 66,163 |  | 80,370 |  |  |
Other Healthcare Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 39,511 |  | 102 |  |  |
Investments at fair value |  | 40,186 |  | 1,366 |  |  |
Energy Efficiency [Member] |  |  |  |  |  |  |
Investments at cost |  | 9,812 |  | 111 |  |  |
Investments at fair value |  | 9,712 |  | 13 |  |  |
Networking Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 10,064 |  | 5,451 |  |  |
Investments at fair value |  | 9,818 |  | 5,297 |  |  |
Data Storage Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 417 |  | 417 |  |  |
Investments at fair value |  | 409 |  | 418 |  |  |
Internet and Media Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 329 |  | 329 |  |  |
Investments at fair value |  | 984 |  | 1,582 |  |  |
Power Management Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 1,585 |  | 1,585 |  |  |
Investments at fair value |  | 2,700 |  | 2,700 |  |  |
Semiconductor Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 45 |  | 45 |  |  |
Investments at fair value |  | 0 |  | 0 |  |  |
Software, Healthcare Information and Service [Member] |  |  |  |  |  |  |
Investments at cost |  | 51,391 |  | 50,899 |  |  |
Investments at fair value |  | 50,905 |  | 50,574 |  |  |
Unrestricted Short Term Investments [Member] |  |  |  |  |  |  |
Investments at cost |  | 31,080 |  | 26,450 |  |  |
Investments at fair value |  | 31,080 |  | 26,450 |  |  |
Unrestricted Short Term Investments [Member] | U S Bank Money Market Deposit Account [Member] |  |  |  |  |  |  |
Investments at cost |  | 31,080 |  | 26,450 |  |  |
Investments at fair value |  | 31,080 |  | 26,450 |  |  |
Equity Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 25,162 |  | 14,443 |  |  |
Investments at fair value |  | 14,037 |  | 7,889 |  |  |
Restricted Short Term Investments [Member] |  |  |  |  |  |  |
Investments at cost |  | 3,266 |  | 2,642 |  |  |
Investments at fair value |  | 3,266 |  | 2,642 |  |  |
Restricted Short Term Investments [Member] | U S Bank Money Market Deposit Account [Member] |  |  |  |  |  |  |
Investments at cost |  | 3,266 |  | 2,642 |  |  |
Investments at fair value |  | 3,266 |  | 2,642 |  |  |
Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 17,292 |  | 16,526 |  |  |
Investments at fair value |  | 18,735 |  | 24,594 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |  |  |  |
Investments at cost |  | 27,478 |  | 28,677 |  |  |
Investments at fair value |  | 8,307 | $ 15,847 | 1,132 | $ 20,485 | $ 906 | $ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] |  |  |  |  |  |  |
Investments at fair value |  | 0 | 0 | $ 0 | 0 | 0 | 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member] |  |  |  |  |  |  |
Investments at fair value | [1] |  |  |  | 0 | 906 | 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.27% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 5,532 |  |  |
Investments at cost |  |  |  | 5,228 |  |  |
Investments at fair value |  |  |  | $ 222 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.27% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 8,298 |  |  |
Investments at cost |  |  |  | 7,867 |  |  |
Investments at fair value |  |  |  | $ 336 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.27% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,319 |  |  |
Investments at cost |  |  |  | 3,137 |  |  |
Investments at fair value |  |  |  | $ 133 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.27% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,319 |  |  |
Investments at cost |  |  |  | 3,137 |  |  |
Investments at fair value |  |  |  | $ 133 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.27% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,213 |  |  |
Investments at cost |  |  |  | 2,091 |  |  |
Investments at fair value |  |  |  | $ 88 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.27% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,213 |  |  |
Investments at cost |  |  |  | 2,091 |  |  |
Investments at fair value |  |  |  | 88 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Common Stock [Member] | Medical Device Sector [Member] | Aulea Medical, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | 0 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 660,537 |  | 660,537 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Common Stock [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at fair value |  | $ 0 |  | $ 132 |  |  |
Number of Shares (in shares) |  | 2,164,502 |  | 2,164,502 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, One [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,770 |  |  |  |  |
Investments at cost |  | 4,910 |  |  |  |  |
Investments at fair value |  | $ 1,825 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Two [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 8,656 |  |  |  |  |
Investments at cost |  | 7,621 |  |  |  |  |
Investments at fair value |  | 2,832 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 5,000 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member] | Life Science [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 5,000 |  |  |
Investments at fair value |  |  |  | $ 132 |  |  |
Number of Shares (in shares) |  |  |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Three [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,462 |  |  |  |  |
Investments at cost |  | 2,947 |  |  |  |  |
Investments at fair value |  | 1,095 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 125 |  | $ 126 |  |  |
Investments at fair value |  | 0 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | 125 |  | 126 |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 23,196 |  | 23,196 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member] | Life Science [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 23,551 |  |  |
Investments at fair value |  |  |  | 1,000 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Four [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,462 |  |  |  |  |
Investments at cost |  | 2,947 |  |  |  |  |
Investments at fair value |  | $ 1,095 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Five [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,308 |  |  |  |  |
Investments at cost |  | 1,964 |  |  |  |  |
Investments at fair value |  | 730 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments [Member] |  |  |  |  |  |  |
Investments at cost |  | 22,353 |  |  |  |  |
Investments at fair value |  | $ 8,307 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments, Prime Index, Six [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,308 |  |  |  |  |
Investments at cost |  | 1,964 |  |  |  |  |
Investments at fair value |  | 730 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] |  |  |  |  |  |  |
Investments at cost |  | 25,353 |  | 14,428 |  |  |
Investments at fair value |  | 19,731 | 11,386 | 14,223 | 13,145 | 0 | 0
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] |  |  |  |  |  |  |
Investments at fair value |  | 6,290 | $ 5,836 | $ 6,230 | $ 6,154 | $ 0 | $ 0
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 3.75% |  |  |
Floor |  |  |  | 12.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 1.85% |  |  |
Maturity Date |  |  |  | Aug. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 3,547 |  |  |
Investments at cost |  |  |  | 3,585 |  |  |
Investments at fair value |  |  |  | $ 3,339 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 3.75% |  |  |
Floor |  |  |  | 12.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 1.85% |  |  |
Maturity Date |  |  |  | Aug. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 1,773 |  |  |
Investments at cost |  |  |  | 1,750 |  |  |
Investments at fair value |  |  |  | 1,630 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Common Stock [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |  |
Investments at cost |  | 2,060 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 2,278,272 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Common Stock [Member] | Technology Sector [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 2,061 |  |  |
Investments at fair value |  |  |  | $ 2,165 |  |  |
Number of Shares (in shares) |  |  |  | 2,278,272 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Common Stock [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 3,297 |  |  |  |  |
Investments at fair value |  | $ 3,309 |  |  |  |  |
Number of Shares (in shares) |  | 108,320 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.78% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 3,891 |  |  |  |  |
Investments at cost |  | 3,935 |  |  |  |  |
Investments at fair value |  | $ 3,234 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index, Five [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 0.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 506 |  |  |  |  |
Investments at cost |  | 507 |  |  |  |  |
Investments at fair value |  | $ 474 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.78% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 1,946 |  |  |  |  |
Investments at cost |  | 1,927 |  |  |  |  |
Investments at fair value |  | 1,583 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 11,276 |  |  |  |  |
Investments at fair value |  | $ 6,549 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member] | Technology Sector [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 3,311 |  |  |
Investments at fair value |  |  |  | 3,024 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index Three [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 0.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 521 |  |  |  |  |
Investments at cost |  | 521 |  |  |  |  |
Investments at fair value |  | $ 489 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index, Four [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 0.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 516 |  |  |  |  |
Investments at cost |  | 517 |  |  |  |  |
Investments at fair value |  | 484 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Preferred Stock [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |  |
Investments at cost |  | 2,500 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 5,350,142 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Preferred Stock [Member] | Technology Sector [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 1,250 |  |  |
Investments at fair value |  |  |  | $ 859 |  |  |
Number of Shares (in shares) |  |  |  | 3,124,448 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Preferred Stock [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 3,419 |  |  |  |  |
Investments at fair value |  | $ 3,240 |  |  |  |  |
Number of Shares (in shares) |  | 542 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 8,197 |  |  |  |  |
Investments at fair value |  | $ 6,892 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member] | Consumer-related Technologies [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 5,335 |  |  |
Investments at fair value |  |  |  | 4,969 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 10.00% |  |  |  |  |
Margin |  | 0.00% |  |  |  |  |
Floor |  | 0.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 0.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 790 |  |  |  |  |
Investments at cost |  | 790 |  |  |  |  |
Investments at fair value |  | 628 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] |  |  |  |  |  |  |
Investments at cost |  | 5,880 |  |  |  |  |
Investments at fair value |  | 6,290 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] | Biotechnology Sector [Member] | HIMV LLC [Member] |  |  |  |  |  |  |
Investments at cost |  | 5,880 |  |  |  |  |
Investments at fair value |  | 6,290 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] | Life Science [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 5,782 |  |  |
Investments at fair value |  |  |  | 6,230 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] | Life Science [Member] | HIMV LLC [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 5,782 |  |  |
Investments at fair value |  |  |  | 6,230 |  |  |
Investment, Unaffiliated Issuer [Member] |  |  |  |  |  |  |
Investments at cost |  | 680,401 |  | 716,077 |  |  |
Investments at fair value |  | $ 655,962 |  | $ 693,730 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,757 |  |  |
Investments at fair value |  |  |  | $ 4,757 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,454 |  |  |
Investments at fair value |  |  |  | 2,454 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 152 |  |  |
Investments at fair value |  |  |  | $ 135 |  |  |
Number of Shares (in shares) |  |  |  | 93,336 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,454 |  |  |
Investments at fair value |  |  |  | $ 2,454 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 5.25% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,467 |  |  |
Investments at fair value |  |  |  | $ 3,467 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 5.25% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,467 |  |  |
Investments at fair value |  |  |  | 3,467 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 71 |  |  |
Investments at fair value |  |  |  | $ 1 |  |  |
Number of Shares (in shares) |  |  |  | 135,484 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 5.25% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,456 |  |  |
Investments at fair value |  |  |  | $ 3,456 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 5.25% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,456 |  |  |
Investments at fair value |  |  |  | $ 3,456 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Nov. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,469 |  |  |
Investments at fair value |  |  |  | $ 1,574 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Nov. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,563 |  |  |
Investments at fair value |  |  |  | 1,617 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Magnolia Medical Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 194 |  |  |
Investments at fair value |  |  |  | $ 368 |  |  |
Number of Shares (in shares) |  |  |  | 809,931 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Meditrina, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 83 |  |  |
Investments at fair value |  |  |  | $ 93 |  |  |
Number of Shares (in shares) |  |  |  | 233,993 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 4.75% |  |  |
Floor |  |  |  | 8.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,722 |  |  |
Investments at fair value |  |  |  | $ 3,722 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 4.75% |  |  |
Floor |  |  |  | 8.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,722 |  |  |
Investments at fair value |  |  |  | 3,722 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 103 |  |  |
Investments at fair value |  |  |  | $ 215 |  |  |
Number of Shares (in shares) |  |  |  | 34,410 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 5.25% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,943 |  |  |
Investments at fair value |  |  |  | $ 4,943 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 5.25% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,900 |  |  |
Investments at fair value |  |  |  | $ 4,900 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 8.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Oct. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,738 |  |  |
Investments at fair value |  |  |  | $ 3,738 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 8.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Oct. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,738 |  |  |
Investments at fair value |  |  |  | 3,738 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 69 |  |  |
Investments at fair value |  |  |  | $ 229 |  |  |
Number of Shares (in shares) |  |  |  | 145,483 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 8.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Oct. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 1,875 |  |  |
Investments at cost |  |  |  | 1,866 |  |  |
Investments at fair value |  |  |  | $ 1,866 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 8.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Oct. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 1,875 |  |  |
Investments at cost |  |  |  | 1,866 |  |  |
Investments at fair value |  |  |  | $ 1,866 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 3.75% |  |  |
Floor |  |  |  | 12.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Jan. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,689 |  |  |
Investments at fair value |  |  |  | $ 3,689 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 3.75% |  |  |
Floor |  |  |  | 12.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Jan. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,689 |  |  |
Investments at fair value |  |  |  | 3,689 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 47 |  |  |
Investments at fair value |  |  |  | $ 47 |  |  |
Number of Shares (in shares) |  |  |  | 103,172 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 3.75% |  |  |
Floor |  |  |  | 12.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 15,000 |  |  |
Investments at cost |  |  |  | 14,675 |  |  |
Investments at fair value |  |  |  | $ 14,675 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 3.75% |  |  |
Floor |  |  |  | 12.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 10,000 |  |  |
Investments at cost |  |  |  | 9,784 |  |  |
Investments at fair value |  |  |  | 9,784 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 432 |  |  |
Investments at fair value |  |  |  | $ 379 |  |  |
Number of Shares (in shares) |  |  |  | 4,109 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 3.75% |  |  |
Floor |  |  |  | 12.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,892 |  |  |
Investments at fair value |  |  |  | $ 4,892 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 3.75% |  |  |
Floor |  |  |  | 12.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,446 |  |  |
Investments at fair value |  |  |  | $ 2,446 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 8.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,297 |  |  |
Investments at fair value |  |  |  | $ 2,297 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 8.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,473 |  |  |
Investments at fair value |  |  |  | 2,473 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 275 |  |  |
Investments at fair value |  |  |  | $ 269 |  |  |
Number of Shares (in shares) |  |  |  | 2,637,043 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 8.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,946 |  |  |
Investments at fair value |  |  |  | $ 4,946 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 8.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,946 |  |  |
Investments at fair value |  |  |  | $ 4,946 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 8.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 6.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 4,583 |  |  |
Investments at cost |  |  |  | 4,546 |  |  |
Investments at fair value |  |  |  | $ 4,546 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 8.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 6.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,292 |  |  |
Investments at cost |  |  |  | 2,273 |  |  |
Investments at fair value |  |  |  | 2,273 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 149 |  |  |
Investments at fair value |  |  |  | $ 167 |  |  |
Number of Shares (in shares) |  |  |  | 4,106,174 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 1.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,978 |  |  |
Investments at fair value |  |  |  | $ 4,978 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 1.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,489 |  |  |
Investments at fair value |  |  |  | $ 2,489 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.32% |  |  |
Margin |  |  |  | 4.82% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 10.36% |  |  |
Maturity Date |  |  |  | Jul. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 3,960 |  |  |
Investments at cost |  |  |  | 3,923 |  |  |
Investments at fair value |  |  |  | $ 3,923 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.32% |  |  |
Margin |  |  |  | 4.82% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 10.36% |  |  |
Maturity Date |  |  |  | Jul. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 3,960 |  |  |
Investments at cost |  |  |  | 3,923 |  |  |
Investments at fair value |  |  |  | 3,923 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 221 |  |  |
Investments at fair value |  |  |  | $ 206 |  |  |
Number of Shares (in shares) |  |  |  | 7,972,222 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 124 |  |  |
Investments at fair value |  |  |  | $ 26 |  |  |
Number of Shares (in shares) |  |  |  | 2,010,424 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Lumithera, Inc. [Member] | Royalty Agreement [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 1,200 |  |  |
Investments at fair value |  |  |  | 200 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | ZetrOZ, Inc [Member] | Royalty Agreement [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | AccuVein Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 24 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 1,175 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerin Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 66 |  |  |
Investments at fair value |  |  |  | $ 1,199 |  |  |
Number of Shares (in shares) |  |  |  | 1,818,183 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 48 |  |  |
Investments at fair value |  |  |  | $ 9 |  |  |
Number of Shares (in shares) |  |  |  | 8,800 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 9.00% |  |  |
Margin |  |  |  | 0.00% |  |  |
Floor |  |  |  | 0.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 18.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,468 |  |  |
Investments at fair value |  |  |  | $ 2,342 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 9.00% |  |  |
Margin |  |  |  | 0.00% |  |  |
Floor |  |  |  | 0.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 18.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,468 |  |  |
Investments at fair value |  |  |  | $ 2,342 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 9.00% |  |  |
Margin |  |  |  | 0.00% |  |  |
Floor |  |  |  | 0.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 18.00% |  |  |
Maturity Date |  |  |  | Jun. 30, 2024 |  |  |
Principal Amount |  |  |  | $ 200 |  |  |
Investments at cost |  |  |  | 200 |  |  |
Investments at fair value |  |  |  | 190 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Canary Medical Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 86 |  |  |
Investments at fair value |  |  |  | $ 1,305 |  |  |
Number of Shares (in shares) |  |  |  | 12,153 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.59% |  |  |
Margin |  |  |  | 5.09% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 500 |  |  |
Investments at cost |  |  |  | 500 |  |  |
Investments at fair value |  |  |  | $ 500 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.59% |  |  |
Margin |  |  |  | 5.09% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 33 |  |  |
Investments at cost |  |  |  | 33 |  |  |
Investments at fair value |  |  |  | 33 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 174 |  |  |
Investments at fair value |  |  |  | $ 124 |  |  |
Number of Shares (in shares) |  |  |  | 3,341,376 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.59% |  |  |
Margin |  |  |  | 5.09% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Mar. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 800 |  |  |
Investments at cost |  |  |  | 794 |  |  |
Investments at fair value |  |  |  | 794 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CVRx, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 76 |  |  |
Investments at fair value |  |  |  | $ 980 |  |  |
Number of Shares (in shares) |  |  |  | 47,410 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Aug. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 1,667 |  |  |
Investments at cost |  |  |  | 1,656 |  |  |
Investments at fair value |  |  |  | $ 1,656 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Aug. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 1,583 |  |  |
Investments at cost |  |  |  | 1,573 |  |  |
Investments at fair value |  |  |  | 1,573 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 29 |  |  |
Investments at fair value |  |  |  | $ 122 |  |  |
Number of Shares (in shares) |  |  |  | 46,745 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.50% |  |  |
Margin |  |  |  | 5.00% |  |  |
Floor |  |  |  | 5.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Mar. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,000 |  |  |
Investments at cost |  |  |  | 1,421 |  |  |
Investments at fair value |  |  |  | $ 1,421 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.50% |  |  |
Margin |  |  |  | 5.00% |  |  |
Floor |  |  |  | 5.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Mar. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,000 |  |  |
Investments at cost |  |  |  | 2,131 |  |  |
Investments at fair value |  |  |  | 2,131 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 2,947 |  |  |
Investments at fair value |  |  |  | $ 2,259 |  |  |
Number of Shares (in shares) |  |  |  | 1,312,500 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 10.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 7.78% |  |  |
Maturity Date |  |  |  | Feb. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,813 |  |  |
Investments at cost |  |  |  | 2,813 |  |  |
Investments at fair value |  |  |  | $ 2,813 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 10.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 7.78% |  |  |
Maturity Date |  |  |  | Feb. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,813 |  |  |
Investments at cost |  |  |  | 2,813 |  |  |
Investments at fair value |  |  |  | $ 2,813 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | CAMP NYC, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.75% |  |  |
Margin |  |  |  | 7.25% |  |  |
Floor |  |  |  | 10.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | May 01, 2026 |  |  |
Principal Amount |  |  |  | $ 3,383 |  |  |
Investments at cost |  |  |  | 3,356 |  |  |
Investments at fair value |  |  |  | 3,356 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | CAMP NYC, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 22 |  |  |
Investments at fair value |  |  |  | $ 27 |  |  |
Number of Shares (in shares) |  |  |  | 75,997 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Lyrical Foods, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 1.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,591 |  |  |
Investments at fair value |  |  |  | $ 2,429 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,608 |  |  |
Investments at fair value |  |  |  | $ 3,608 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 1,250 |  |  |
Investments at cost |  |  |  | 1,242 |  |  |
Investments at fair value |  |  |  | 1,242 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 94 |  |  |
Investments at fair value |  |  |  | $ 250 |  |  |
Number of Shares (in shares) |  |  |  | 37,282 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,726 |  |  |
Investments at fair value |  |  |  | $ 3,726 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 1,250 |  |  |
Investments at cost |  |  |  | 1,242 |  |  |
Investments at fair value |  |  |  | $ 1,242 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,726 |  |  |
Investments at fair value |  |  |  | $ 3,726 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 1,250 |  |  |
Investments at cost |  |  |  | 1,242 |  |  |
Investments at fair value |  |  |  | $ 1,242 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,712 |  |  |
Investments at fair value |  |  |  | $ 3,712 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,712 |  |  |
Investments at fair value |  |  |  | $ 3,712 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,706 |  |  |
Investments at fair value |  |  |  | $ 3,706 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,707 |  |  |
Investments at fair value |  |  |  | $ 3,707 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.25% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 11.25% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,707 |  |  |
Investments at fair value |  |  |  | $ 3,707 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.25% |  |  |
Maturity Date |  |  |  | Oct. 31, 2023 |  |  |
Principal Amount |  |  |  | $ 5,752 |  |  |
Investments at cost |  |  |  | 5,752 |  |  |
Investments at fair value |  |  |  | $ 5,018 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.25% |  |  |
Maturity Date |  |  |  | Oct. 31, 2023 |  |  |
Principal Amount |  |  |  | $ 2,301 |  |  |
Investments at cost |  |  |  | 2,301 |  |  |
Investments at fair value |  |  |  | 2,007 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 188 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 12,618 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 9 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 1,224,752 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.25% |  |  |
Maturity Date |  |  |  | Oct. 31, 2023 |  |  |
Principal Amount |  |  |  | $ 2,876 |  |  |
Investments at cost |  |  |  | 2,876 |  |  |
Investments at fair value |  |  |  | $ 2,509 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.25% |  |  |
Maturity Date |  |  |  | Oct. 31, 2023 |  |  |
Principal Amount |  |  |  | $ 3,451 |  |  |
Investments at cost |  |  |  | 3,451 |  |  |
Investments at fair value |  |  |  | $ 3,011 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.25% |  |  |
Maturity Date |  |  |  | Oct. 31, 2023 |  |  |
Principal Amount |  |  |  | $ 2,876 |  |  |
Investments at cost |  |  |  | 2,876 |  |  |
Investments at fair value |  |  |  | $ 2,510 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.25% |  |  |
Maturity Date |  |  |  | Oct. 31, 2023 |  |  |
Principal Amount |  |  |  | $ 2,876 |  |  |
Investments at cost |  |  |  | 2,876 |  |  |
Investments at fair value |  |  |  | $ 2,510 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.25% |  |  |
Maturity Date |  |  |  | Oct. 31, 2023 |  |  |
Principal Amount |  |  |  | $ 5,752 |  |  |
Investments at cost |  |  |  | 5,752 |  |  |
Investments at fair value |  |  |  | $ 5,018 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.25% |  |  |
Maturity Date |  |  |  | Oct. 31, 2023 |  |  |
Principal Amount |  |  |  | $ 2,876 |  |  |
Investments at cost |  |  |  | 2,876 |  |  |
Investments at fair value |  |  |  | 2,510 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Alula Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 93 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 20,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Aterian, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 195 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 76,923 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Caastle, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 65 |  |  |
Investments at fair value |  |  |  | $ 1,055 |  |  |
Number of Shares (in shares) |  |  |  | 268,591 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,416 |  |  |
Investments at fair value |  |  |  | $ 2,416 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 1,875 |  |  |
Investments at cost |  |  |  | 1,787 |  |  |
Investments at fair value |  |  |  | 1,787 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 182 |  |  |
Investments at fair value |  |  |  | $ 145 |  |  |
Number of Shares (in shares) |  |  |  | 11,550 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | CZV, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 81 |  |  |
Investments at fair value |  |  |  | $ 71 |  |  |
Number of Shares (in shares) |  |  |  | 65,569 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 16.25% |  |  |
Margin |  |  |  | 7.75% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | May 01, 2027 |  |  |
Principal Amount |  |  |  | $ 1,204 |  |  |
Investments at cost |  |  |  | 1,086 |  |  |
Investments at fair value |  |  |  | $ 872 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 16.25% |  |  |
Margin |  |  |  | 7.75% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | May 01, 2027 |  |  |
Principal Amount |  |  |  | $ 602 |  |  |
Investments at cost |  |  |  | 543 |  |  |
Investments at fair value |  |  |  | 436 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 32 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 171,081 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 16.25% |  |  |
Margin |  |  |  | 7.75% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | May 01, 2027 |  |  |
Principal Amount |  |  |  | $ 602 |  |  |
Investments at cost |  |  |  | 543 |  |  |
Investments at fair value |  |  |  | $ 436 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 3,667 |  |  |
Investments at cost |  |  |  | 3,647 |  |  |
Investments at fair value |  |  |  | $ 3,647 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 1,833 |  |  |
Investments at cost |  |  |  | 1,824 |  |  |
Investments at fair value |  |  |  | 1,824 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | MyForest Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 29 |  |  |
Investments at fair value |  |  |  | $ 56 |  |  |
Number of Shares (in shares) |  |  |  | 250 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Primary Kids, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 57 |  |  |
Investments at fair value |  |  |  | $ 591 |  |  |
Number of Shares (in shares) |  |  |  | 553,778 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Quip NYC Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 325 |  |  |
Investments at fair value |  |  |  | $ 533 |  |  |
Number of Shares (in shares) |  |  |  | 6,191 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Updater, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 34 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 114,659 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 214 |  |  |
Investments at fair value |  |  |  | $ 318 |  |  |
Number of Shares (in shares) |  |  |  | 7,404 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Avalo Therapeutics, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 311 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 117 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 178 |  |  |
Investments at fair value |  |  |  | $ 246 |  |  |
Number of Shares (in shares) |  |  |  | 110,402 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Imunon, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 65 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 19,671 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 50 |  |  |
Investments at fair value |  |  |  | $ 53 |  |  |
Number of Shares (in shares) |  |  |  | 48,076 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Mustang Bio, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 146 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 16,611 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 64 |  |  |
Investments at fair value |  |  |  | $ 157 |  |  |
Number of Shares (in shares) |  |  |  | 103,679 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 160 |  |  |
Investments at fair value |  |  |  | $ 606 |  |  |
Number of Shares (in shares) |  |  |  | 299,848 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 278 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 175,098 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 312 |  |  |
Investments at fair value |  |  |  | $ 225 |  |  |
Number of Shares (in shares) |  |  |  | 691,895 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 264 |  |  |
Investments at fair value |  |  |  | $ 113 |  |  |
Number of Shares (in shares) |  |  |  | 318,181 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 12.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,459 |  |  |
Investments at fair value |  |  |  | 2,459 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 194 |  |  |
Investments at fair value |  |  |  | $ 172 |  |  |
Number of Shares (in shares) |  |  |  | 1,600,002 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Xeris Pharmaceuticals, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 72 |  |  |
Investments at fair value |  |  |  | $ 33 |  |  |
Number of Shares (in shares) |  |  |  | 126,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 10,000 |  |  |
Investments at cost |  |  |  | 9,895 |  |  |
Investments at fair value |  |  |  | $ 9,895 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 10,000 |  |  |
Investments at cost |  |  |  | 9,895 |  |  |
Investments at fair value |  |  |  | 9,895 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 273 |  |  |
Investments at fair value |  |  |  | $ 13 |  |  |
Number of Shares (in shares) |  |  |  | 639,918 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,947 |  |  |
Investments at fair value |  |  |  | $ 4,947 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,947 |  |  |
Investments at fair value |  |  |  | 4,947 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 167 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 85,066 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.00% |  |  |
Margin |  |  |  | 6.50% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 6,625 |  |  |
Investments at cost |  |  |  | 6,519 |  |  |
Investments at fair value |  |  |  | $ 6,176 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.00% |  |  |
Margin |  |  |  | 6.50% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 6,116 |  |  |
Investments at cost |  |  |  | 6,018 |  |  |
Investments at fair value |  |  |  | 5,701 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 455 |  |  |
Investments at fair value |  |  |  | $ 46 |  |  |
Number of Shares (in shares) |  |  |  | 516,732 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.00% |  |  |
Margin |  |  |  | 6.50% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Aug. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,548 |  |  |
Investments at cost |  |  |  | 2,507 |  |  |
Investments at fair value |  |  |  | $ 2,375 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.50% |  |  |
Margin |  |  |  | 5.00% |  |  |
Floor |  |  |  | 12.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Mar. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 10,000 |  |  |
Investments at cost |  |  |  | 9,885 |  |  |
Investments at fair value |  |  |  | $ 9,885 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.50% |  |  |
Margin |  |  |  | 5.00% |  |  |
Floor |  |  |  | 12.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Mar. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,942 |  |  |
Investments at fair value |  |  |  | 4,942 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 115 |  |  |
Investments at fair value |  |  |  | $ 2 |  |  |
Number of Shares (in shares) |  |  |  | 84,037 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.50% |  |  |
Margin |  |  |  | 5.00% |  |  |
Floor |  |  |  | 12.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Mar. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,942 |  |  |
Investments at fair value |  |  |  | $ 4,942 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Reputation Institute, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.75% |  |  |
Margin |  |  |  | 7.25% |  |  |
Floor |  |  |  | 10.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 3,667 |  |  |
Investments at cost |  |  |  | 3,625 |  |  |
Investments at fair value |  |  |  | 3,625 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Reputation Institute, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 56 |  |  |
Investments at fair value |  |  |  | $ 80 |  |  |
Number of Shares (in shares) |  |  |  | 3,731 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Revinate Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 44 |  |  |
Investments at fair value |  |  |  | $ 91 |  |  |
Number of Shares (in shares) |  |  |  | 682,034 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Engage3, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.50% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,728 |  |  |
Investments at fair value |  |  |  | $ 3,728 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Engage3, LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.50% |  |  |
Maturity Date |  |  |  | Jul. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,728 |  |  |
Investments at fair value |  |  |  | $ 3,728 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 14.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Nov. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,471 |  |  |
Investments at fair value |  |  |  | $ 2,373 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 14.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Dec. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 1,250 |  |  |
Investments at cost |  |  |  | 1,237 |  |  |
Investments at fair value |  |  |  | 1,188 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lytics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 43 |  |  |
Investments at fair value |  |  |  | $ 1 |  |  |
Number of Shares (in shares) |  |  |  | 85,543 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 14.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 1,000 |  |  |
Investments at cost |  |  |  | 994 |  |  |
Investments at fair value |  |  |  | 954 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SIGNiX, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 225 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 186,235 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,959 |  |  |
Investments at fair value |  |  |  | $ 4,959 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,959 |  |  |
Investments at fair value |  |  |  | 4,959 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 123 |  |  |
Investments at fair value |  |  |  | $ 135 |  |  |
Number of Shares (in shares) |  |  |  | 309,208 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,959 |  |  |
Investments at fair value |  |  |  | $ 4,959 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,959 |  |  |
Investments at fair value |  |  |  | 4,959 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Health Research, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 192 |  |  |
Investments at fair value |  |  |  | $ 99 |  |  |
Number of Shares (in shares) |  |  |  | 652,250 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,779 |  |  |
Investments at fair value |  |  |  | $ 4,779 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,915 |  |  |
Investments at fair value |  |  |  | 4,915 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 223 |  |  |
Investments at fair value |  |  |  | $ 247 |  |  |
Number of Shares (in shares) |  |  |  | 948,275 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,915 |  |  |
Investments at fair value |  |  |  | $ 4,915 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,915 |  |  |
Investments at fair value |  |  |  | 4,915 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Topia Mobility, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 138 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 3,049,607 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Medsphere Systems Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 60 |  |  |
Investments at fair value |  |  |  | $ 108 |  |  |
Number of Shares (in shares) |  |  |  | 7,097,792 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SafelyYou, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 163 |  |  |
Investments at fair value |  |  |  | $ 50 |  |  |
Number of Shares (in shares) |  |  |  | 150,353 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.50% |  |  |
Margin |  |  |  | 4.00% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,773 |  |  |
Investments at fair value |  |  |  | $ 4,773 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.50% |  |  |
Margin |  |  |  | 4.00% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,467 |  |  |
Investments at fair value |  |  |  | 2,467 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 120 |  |  |
Investments at fair value |  |  |  | $ 105 |  |  |
Number of Shares (in shares) |  |  |  | 345,443 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.50% |  |  |
Margin |  |  |  | 4.00% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,467 |  |  |
Investments at fair value |  |  |  | 2,467 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | xAd, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 177 |  |  |
Investments at fair value |  |  |  | $ 5 |  |  |
Number of Shares (in shares) |  |  |  | 4,343,348 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.00% |  |  |
Margin |  |  |  | 6.50% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Mar. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,971 |  |  |
Investments at fair value |  |  |  | $ 4,971 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.00% |  |  |
Margin |  |  |  | 6.50% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Mar. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,486 |  |  |
Investments at fair value |  |  |  | 2,486 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lemongrass Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 32 |  |  |
Investments at fair value |  |  |  | $ 120 |  |  |
Number of Shares (in shares) |  |  |  | 101,308 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 12.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,457 |  |  |
Investments at fair value |  |  |  | $ 2,457 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 12.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,489 |  |  |
Investments at fair value |  |  |  | 3,489 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 64 |  |  |
Investments at fair value |  |  |  | $ 135 |  |  |
Number of Shares (in shares) |  |  |  | 682 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 12.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,492 |  |  |
Investments at fair value |  |  |  | $ 2,492 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 4.25% |  |  |
Floor |  |  |  | 12.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 1,500 |  |  |
Investments at cost |  |  |  | 1,495 |  |  |
Investments at fair value |  |  |  | $ 1,495 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 14.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,860 |  |  |
Investments at fair value |  |  |  | $ 4,860 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 14.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,466 |  |  |
Investments at fair value |  |  |  | 2,466 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 98 |  |  |
Investments at fair value |  |  |  | $ 174 |  |  |
Number of Shares (in shares) |  |  |  | 161,215 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 14.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,466 |  |  |
Investments at fair value |  |  |  | $ 2,466 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 14.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,466 |  |  |
Investments at fair value |  |  |  | 2,466 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 18 |  |  |
Investments at fair value |  |  |  | $ 42 |  |  |
Number of Shares (in shares) |  |  |  | 71,305 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | E La Carte, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 60 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 147,361 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Everstream Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 70 |  |  |
Investments at fair value |  |  |  | $ 63 |  |  |
Number of Shares (in shares) |  |  |  | 350,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 4,375 |  |  |  |  |
Investments at cost |  | 4,354 |  |  |  |  |
Investments at fair value |  | 4,354 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 6,250 |  |  |
Investments at cost |  |  |  | 6,218 |  |  |
Investments at fair value |  |  |  | $ 6,218 |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 6,250 |  |  |
Investments at cost |  |  |  | 6,218 |  |  |
Investments at fair value |  |  |  | 6,218 |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 47 |  |  |
Investments at fair value |  |  |  | $ 61 |  |  |
Number of Shares (in shares) |  |  |  | 1,991 |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 6,250 |  |  |
Investments at cost |  |  |  | 6,218 |  |  |
Investments at fair value |  |  |  | 6,218 |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Intelepeer Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 138 |  |  |
Investments at fair value |  |  |  | $ 3,036 |  |  |
Number of Shares (in shares) |  |  |  | 2,936,535 |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | PebblePost, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 92 |  |  |
Investments at fair value |  |  |  | $ 131 |  |  |
Number of Shares (in shares) |  |  |  | 598,850 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 10,321 |  |  |  |  |
Investments at fair value |  | 12,023 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,484 |  |  |
Investments at fair value |  |  |  | $ 2,484 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,484 |  |  |
Investments at fair value |  |  |  | 2,484 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 46 |  |  |
Investments at fair value |  |  |  | $ 12 |  |  |
Number of Shares (in shares) |  |  |  | 171,370 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.50% |  |  |
Maturity Date |  |  |  | Jun. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,968 |  |  |
Investments at fair value |  |  |  | $ 4,968 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 3.25% |  |  |
Floor |  |  |  | 11.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,633 |  |  |
Investments at fair value |  |  |  | $ 4,633 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 3.25% |  |  |
Floor |  |  |  | 11.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,884 |  |  |
Investments at fair value |  |  |  | 4,884 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 70 |  |  |
Investments at fair value |  |  |  | $ 70 |  |  |
Number of Shares (in shares) |  |  |  | 32,244 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 166 |  |  |
Investments at fair value |  |  |  | $ 166 |  |  |
Number of Shares (in shares) |  |  |  | 184,253 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.33% |  |  |
Maturity Date |  |  |  | Dec. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,685 |  |  |
Investments at fair value |  |  |  | $ 3,685 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.33% |  |  |
Maturity Date |  |  |  | Dec. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,685 |  |  |
Investments at fair value |  |  |  | 3,685 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 81 |  |  |
Investments at fair value |  |  |  | $ 72 |  |  |
Number of Shares (in shares) |  |  |  | 400,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 8,425 |  |  |
Investments at cost |  |  |  | 8,353 |  |  |
Investments at fair value |  |  |  | $ 4,549 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 8,425 |  |  |
Investments at cost |  |  |  | 8,229 |  |  |
Investments at fair value |  |  |  | 4,481 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 490 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 215,171 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 8,425 |  |  |
Investments at cost |  |  |  | 8,229 |  |  |
Investments at fair value |  |  |  | $ 4,481 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 5,617 |  |  |
Investments at cost |  |  |  | 5,480 |  |  |
Investments at fair value |  |  |  | $ 2,984 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 5,617 |  |  |
Investments at cost |  |  |  | 5,480 |  |  |
Investments at fair value |  |  |  | $ 2,984 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 735 |  |  |
Investments at cost |  |  |  | 726 |  |  |
Investments at fair value |  |  |  | $ 395 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 586 |  |  |
Investments at cost |  |  |  | 578 |  |  |
Investments at fair value |  |  |  | $ 315 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 292 |  |  |
Investments at cost |  |  |  | 288 |  |  |
Investments at fair value |  |  |  | $ 157 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 290 |  |  |
Investments at cost |  |  |  | 286 |  |  |
Investments at fair value |  |  |  | $ 156 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 174 |  |  |
Investments at cost |  |  |  | 172 |  |  |
Investments at fair value |  |  |  | $ 93 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 802 |  |  |
Investments at cost |  |  |  | 791 |  |  |
Investments at fair value |  |  |  | $ 431 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Twelve [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.50% |  |  |
Margin |  |  |  | 7.00% |  |  |
Floor |  |  |  | 10.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 0.00% |  |  |
Maturity Date |  |  |  | Mar. 31, 2024 |  |  |
Principal Amount |  |  |  | $ 1,091 |  |  |
Investments at cost |  |  |  | 1,083 |  |  |
Investments at fair value |  |  |  | 590 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | LiquiGlide, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 39 |  |  |
Investments at fair value |  |  |  | $ 50 |  |  |
Number of Shares (in shares) |  |  |  | 61,359 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.75% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,959 |  |  |
Investments at fair value |  |  |  | $ 4,959 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.75% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,479 |  |  |
Investments at fair value |  |  |  | 2,479 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 214 |  |  |
Investments at fair value |  |  |  | $ 340 |  |  |
Number of Shares (in shares) |  |  |  | 681 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.75% |  |  |
Maturity Date |  |  |  | May 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,956 |  |  |
Investments at fair value |  |  |  | $ 4,956 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.75% |  |  |
Maturity Date |  |  |  | May 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,478 |  |  |
Investments at fair value |  |  |  | $ 2,478 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.75% |  |  |
Maturity Date |  |  |  | Dec. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,934 |  |  |
Investments at fair value |  |  |  | $ 4,934 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.75% |  |  |
Maturity Date |  |  |  | Dec. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,467 |  |  |
Investments at fair value |  |  |  | $ 2,467 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Apr. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,694 |  |  |
Investments at fair value |  |  |  | $ 3,694 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Apr. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,694 |  |  |
Investments at fair value |  |  |  | 3,694 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 175 |  |  |
Investments at fair value |  |  |  | $ 80 |  |  |
Number of Shares (in shares) |  |  |  | 46,311 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Apr. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 7,500 |  |  |
Investments at cost |  |  |  | 7,379 |  |  |
Investments at fair value |  |  |  | $ 7,379 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Apr. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,690 |  |  |
Investments at fair value |  |  |  | $ 3,690 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 15.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.50% |  |  |
Maturity Date |  |  |  | Apr. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,690 |  |  |
Investments at fair value |  |  |  | $ 3,690 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 4,500 |  |  |
Investments at cost |  |  |  | 4,446 |  |  |
Investments at fair value |  |  |  | $ 4,446 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.50% |  |  |
Margin |  |  |  | 6.00% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 2.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2029 |  |  |
Principal Amount |  |  |  | $ 2,000 |  |  |
Investments at cost |  |  |  | 1,976 |  |  |
Investments at fair value |  |  |  | 1,976 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Kate Farms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 102 |  |  |
Investments at fair value |  |  |  | $ 1,366 |  |  |
Number of Shares (in shares) |  |  |  | 82,965 |  |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 1,500 |  |  |
Investments at cost |  |  |  | 1,481 |  |  |
Investments at fair value |  |  |  | $ 1,481 |  |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 1,500 |  |  |
Investments at cost |  |  |  | 1,481 |  |  |
Investments at fair value |  |  |  | 1,481 |  |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 364 |  |  |
Investments at fair value |  |  |  | $ 210 |  |  |
Number of Shares (in shares) |  |  |  | 344,102 |  |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 750 |  |  |
Investments at cost |  |  |  | 740 |  |  |
Investments at fair value |  |  |  | $ 740 |  |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 667 |  |  |
Investments at cost |  |  |  | 656 |  |  |
Investments at fair value |  |  |  | $ 656 |  |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 750 |  |  |
Investments at cost |  |  |  | 729 |  |  |
Investments at fair value |  |  |  | 729 |  |  |
Investment, Unaffiliated Issuer [Member] | Data Storage Sector [Member] | CPG Beyond, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 242 |  |  |
Investments at fair value |  |  |  | $ 294 |  |  |
Number of Shares (in shares) |  |  |  | 500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Data Storage Sector [Member] | Silk, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 175 |  |  |
Investments at fair value |  |  |  | $ 124 |  |  |
Number of Shares (in shares) |  |  |  | 394,110 |  |  |
Investment, Unaffiliated Issuer [Member] | Internet and Media Sector [Member] | Global Worldwide LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 75 |  |  |
Investments at fair value |  |  |  | $ 63 |  |  |
Number of Shares (in shares) |  |  |  | 245,810 |  |  |
Investment, Unaffiliated Issuer [Member] | Internet and Media Sector [Member] | Rocket Lawyer Incorporated [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 92 |  |  |
Investments at fair value |  |  |  | $ 318 |  |  |
Number of Shares (in shares) |  |  |  | 261,721 |  |  |
Investment, Unaffiliated Issuer [Member] | Internet and Media Sector [Member] | Skillshare, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 162 |  |  |
Investments at fair value |  |  |  | $ 1,201 |  |  |
Number of Shares (in shares) |  |  |  | 139,074 |  |  |
Investment, Unaffiliated Issuer [Member] | Power Management Sector [Member] | Halio, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 1,585 |  |  |
Investments at fair value |  |  |  | $ 2,700 |  |  |
Number of Shares (in shares) |  |  |  | 38,241,466 |  |  |
Investment, Unaffiliated Issuer [Member] | Semiconductor Sector [Member] | Avalanche Technology, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 45 |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  |  |  | 5,938 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 7,000 |  |  |
Investments at cost |  |  |  | 6,684 |  |  |
Investments at fair value |  |  |  | $ 6,684 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,463 |  |  |
Investments at fair value |  |  |  | $ 3,463 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,463 |  |  |
Investments at fair value |  |  |  | $ 3,463 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 2,750 |  |  |
Investments at cost |  |  |  | 2,710 |  |  |
Investments at fair value |  |  |  | $ 2,710 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 10,000 |  |  |
Investments at cost |  |  |  | 9,656 |  |  |
Investments at fair value |  |  |  | $ 9,656 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,925 |  |  |
Investments at fair value |  |  |  | $ 4,925 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,925 |  |  |
Investments at fair value |  |  |  | $ 4,925 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.00% |  |  |
Margin |  |  |  | 3.50% |  |  |
Floor |  |  |  | 11.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,925 |  |  |
Investments at fair value |  |  |  | $ 4,925 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 3.25% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jun. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,648 |  |  |
Investments at fair value |  |  |  | $ 4,648 |  |  |
Investment, Unaffiliated Issuer [Member] | Software, Healthcare Information and Service [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 3.25% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jun. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,918 |  |  |
Investments at fair value |  |  |  | 4,918 |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Castle Creek Biosciences, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | 250 |  |  |  |  |
Investments at fair value |  | $ 250 |  |  |  |  |
Number of Shares (in shares) |  | 1,162 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Emalex Biosciences, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 356 |  |  |  |  |
Investments at fair value |  | $ 356 |  |  |  |  |
Number of Shares (in shares) |  | 32,831 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Lumithera, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 2,000 |  |  |  |  |
Investments at fair value |  | $ 1,700 |  |  |  |  |
Number of Shares (in shares) |  | 392,651 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Cadrenal Therapeutics, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  |  |  |  |
Investments at fair value |  | $ 546 |  |  |  |  |
Number of Shares (in shares) |  | 600,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Getaround, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 253 |  |  |  |  |
Investments at fair value |  | $ 5 |  |  |  |  |
Number of Shares (in shares) |  | 87,082 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | SnagAJob.com, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 7 |  |  |  |  |
Investments at fair value |  | $ 83 |  |  |  |  |
Number of Shares (in shares) |  | 82,974 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Tigo Energy, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 111 |  |  |  |  |
Investments at fair value |  | $ 11 |  |  |  |  |
Number of Shares (in shares) |  | 5,205 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Medical Device Sector [Member] | Lumithera, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 2,000 |  |  |
Investments at fair value |  |  |  | $ 1,700 |  |  |
Number of Shares (in shares) |  |  |  | 392,651 |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Consumer-related Technologies [Member] | Getaround, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 253 |  |  |
Investments at fair value |  |  |  | $ 20 |  |  |
Number of Shares (in shares) |  |  |  | 87,082 |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Consumer-related Technologies [Member] | SnagAJob.com, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 9 |  |  |
Investments at fair value |  |  |  | $ 83 |  |  |
Number of Shares (in shares) |  |  |  | 82,974 |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 250 |  |  |
Investments at fair value |  |  |  | $ 250 |  |  |
Number of Shares (in shares) |  |  |  | 1,162 |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 355 |  |  |
Investments at fair value |  |  |  | $ 355 |  |  |
Number of Shares (in shares) |  |  |  | 32,831 |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Biotechnology Sector [Member] | Cadrenal Therapeutics, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  |  |  |  |
Investments at fair value |  |  |  | $ 443 |  |  |
Number of Shares (in shares) |  |  |  | 600,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock [Member] | Other Sustainability Sector [Member] | Tigo Energy, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 111 |  |  |
Investments at fair value |  |  |  | $ 13 |  |  |
Number of Shares (in shares) |  |  |  | 5,205 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.50% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,777 |  |  |  |  |
Investments at fair value |  | $ 4,777 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,510 |  |  |  |  |
Investments at fair value |  | $ 3,509 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  |  |  |  |
Margin |  | 4.75% |  |  |  |  |
Floor |  | 8.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,734 |  |  |  |  |
Investments at fair value |  | $ 3,734 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 10.75% |  |  |  |  |
Margin |  | 2.75% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,817 |  |  |  |  |
Investments at fair value |  | $ 4,817 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jan. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,696 |  |  |  |  |
Investments at fair value |  | $ 3,696 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 15,000 |  |  |  |  |
Investments at cost |  | 14,719 |  |  |  |  |
Investments at fair value |  | $ 14,117 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 8.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,479 |  |  |  |  |
Investments at fair value |  | $ 2,479 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 8.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 6.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 3,611 |  |  |  |  |
Investments at cost |  | 3,584 |  |  |  |  |
Investments at fair value |  | $ 3,356 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 1.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,911 |  |  |  |  |
Investments at fair value |  | $ 4,911 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.82% |  |  |  |  |
Margin |  | 4.82% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 10.36% |  |  |  |  |
Maturity Date |  | Jul. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 3,477 |  |  |  |  |
Investments at cost |  | 3,448 |  |  |  |  |
Investments at fair value |  | $ 3,448 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 4.50% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,916 |  |  |  |  |
Investments at fair value |  | $ 4,916 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.50% |  |  |  |  |
Maturity Date |  | Aug. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 833 |  |  |  |  |
Investments at cost |  | 828 |  |  |  |  |
Investments at fair value |  | $ 828 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 5.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 10.40% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,000 |  |  |  |  |
Investments at cost |  | 1,467 |  |  |  |  |
Investments at fair value |  | $ 1,467 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | CAMP NYC, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  |  |  |  |
Margin |  | 7.25% |  |  |  |  |
Floor |  | 10.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,033 |  |  |  |  |
Investments at cost |  | 1,980 |  |  |  |  |
Investments at fair value |  | $ 1,922 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Lyrical Foods, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.50% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,603 |  |  |  |  |
Investments at cost |  | 2,692 |  |  |  |  |
Investments at fair value |  | $ 2,341 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.25% |  |  |  |  |
Maturity Date |  | Oct. 31, 2023 |  |  |  |  |
Principal Amount |  | $ 5,908 |  |  |  |  |
Investments at cost |  | 5,489 |  |  |  |  |
Investments at fair value |  | $ 3,256 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.25% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,440 |  |  |  |  |
Investments at fair value |  | $ 2,440 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Jun. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,245 |  |  |  |  |
Investments at fair value |  | $ 2,245 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.75% |  |  |  |  |
Margin |  | 7.75% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 0.00% |  |  |  |  |
Maturity Date |  | May 01, 2027 |  |  |  |  |
Principal Amount |  | $ 1,361 |  |  |  |  |
Investments at cost |  | 1,086 |  |  |  |  |
Investments at fair value |  | $ 228 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 13.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 3,958 |  | $ 5,000 |  |  |
Investments at cost |  | 3,948 |  | 4,979 |  |  |
Investments at fair value |  | $ 3,948 |  | $ 4,979 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.72% |  | 13.22% |  |  |
Margin |  | 4.72% |  | 4.72% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Nov. 01, 2025 |  | Jun. 01, 2024 |  |  |
Principal Amount |  | $ 5,000 |  | $ 1,414 |  |  |
Investments at cost |  | 4,970 |  | 1,410 |  |  |
Investments at fair value |  | $ 4,970 |  | $ 1,410 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  | 13.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2027 |  | May 01, 2027 |  |  |
Principal Amount |  | $ 6,250 |  | $ 6,250 |  |  |
Investments at cost |  | 6,215 |  | 6,199 |  |  |
Investments at fair value |  | $ 6,215 |  | $ 6,199 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 13.75% |  |  |
Margin |  | 5.25% |  | 5.25% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Nov. 01, 2026 |  | Nov. 01, 2026 |  |  |
Principal Amount |  | $ 3,250 |  | $ 3,750 |  |  |
Investments at cost |  | 3,234 |  | 3,716 |  |  |
Investments at fair value |  | $ 3,234 |  | $ 3,716 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  | 14.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2025 |  | Jul. 01, 2025 |  |  |
Principal Amount |  | $ 1,667 |  | $ 3,000 |  |  |
Investments at cost |  | 1,624 |  | 2,914 |  |  |
Investments at fair value |  | $ 1,624 |  | $ 2,870 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  | 14.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.75% |  | 3.75% |  |  |
Maturity Date |  | Sep. 01, 2026 |  | Sep. 01, 2026 |  |  |
Principal Amount |  | $ 10,000 |  | $ 10,000 |  |  |
Investments at cost |  | 9,950 |  | 9,911 |  |  |
Investments at fair value |  | $ 9,950 |  | $ 9,911 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.36% |  | 13.86% |  |  |
Margin |  | 5.36% |  | 5.36% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.30% |  | 5.50% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Dec. 01, 2024 |  |  |
Principal Amount |  | $ 3,482 |  | $ 4,666 |  |  |
Investments at cost |  | 3,410 |  | 4,579 |  |  |
Investments at fair value |  | $ 3,218 |  | $ 4,414 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 14.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 8.75% |  | 8.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 6.00% |  | 6.00% |  |  |
Maturity Date |  | Oct. 01, 2025 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 2,631 |  | $ 4,250 |  |  |
Investments at cost |  | 2,598 |  | 4,193 |  |  |
Investments at fair value |  | $ 2,598 |  | $ 4,193 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  | 12.75% |  |  |
Margin |  | 4.25% |  | 4.25% |  |  |
Floor |  | 12.25% |  | 12.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Aug. 01, 2027 |  | Aug. 01, 2027 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,468 |  | 2,230 |  |  |
Investments at fair value |  | $ 2,468 |  | $ 2,230 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 10.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 10,000 |  |  |  |  |
Investments at cost |  | 9,946 |  |  |  |  |
Investments at fair value |  | $ 9,946 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 7,000 |  |  |  |  |
Investments at cost |  | 6,814 |  |  |  |  |
Investments at fair value |  | $ 6,814 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | DropOff, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.50% |  |  |  |  |
Floor |  | 9.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 6,804 |  |  |  |  |
Investments at cost |  | 6,729 |  |  |  |  |
Investments at fair value |  | $ 6,337 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 10,000 |  |  |  |  |
Investments at cost |  | 9,916 |  |  |  |  |
Investments at fair value |  | $ 9,916 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Reputation Institute, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.75% |  |  |  |  |
Margin |  | 7.25% |  |  |  |  |
Floor |  | 10.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 1,933 |  |  |  |  |
Investments at cost |  | 1,901 |  |  |  |  |
Investments at fair value |  | $ 1,901 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Lytics, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 14.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Nov. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,479 |  |  |  |  |
Investments at fair value |  | $ 2,479 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.75% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 10,000 |  |  |  |  |
Investments at cost |  | 9,783 |  |  |  |  |
Investments at fair value |  | $ 9,783 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Mirantis, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,929 |  |  |  |  |
Investments at fair value |  | $ 4,929 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | SafelyYou, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,791 |  |  |  |  |
Investments at fair value |  | $ 4,791 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Viken Detection Corporation [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 4.00% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,951 |  |  |  |  |
Investments at fair value |  | $ 4,951 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,476 |  |  |  |  |
Investments at fair value |  | $ 2,476 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 14.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,905 |  |  |  |  |
Investments at fair value |  | $ 4,905 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 1,607 |  |  |  |  |
Investments at cost |  | 1,577 |  |  |  |  |
Investments at fair value |  | $ 1,034 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.75% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,652 |  |  |  |  |
Investments at fair value |  | $ 4,652 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.33% |  |  |  |  |
Maturity Date |  | Dec. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,712 |  |  |  |  |
Investments at fair value |  | $ 3,712 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.75% |  |  |  |  |
Maturity Date |  | Apr. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,937 |  |  |  |  |
Investments at fair value |  | $ 4,937 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,703 |  |  |  |  |
Investments at fair value |  | $ 3,703 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,592 |  |  |  |  |
Investments at fair value |  | $ 3,592 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,851 |  |  |  |  |
Investments at fair value |  | $ 4,851 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 4.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Feb. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,739 |  |  |  |  |
Investments at fair value |  | $ 4,739 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] | Networking Sector [Member] | Fictiv, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,703 |  |  |  |  |
Investments at fair value |  | $ 4,703 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 100.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 300 |  |  |  |  |
Investments at cost |  | 300 |  |  |  |  |
Investments at fair value |  | $ 300 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 8.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,711 |  |  |  |  |
Investments at fair value |  | $ 3,711 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.25% |  |  |  |  |
Maturity Date |  | Oct. 31, 2023 |  |  |  |  |
Principal Amount |  | $ 2,954 |  |  |  |  |
Investments at cost |  | 2,745 |  |  |  |  |
Investments at fair value |  | $ 1,628 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 13.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 3,958 |  | $ 5,000 |  |  |
Investments at cost |  | 3,949 |  | 4,979 |  |  |
Investments at fair value |  | $ 3,949 |  | $ 4,979 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.36% |  | 13.86% |  |  |
Margin |  | 5.36% |  | 5.36% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.31% |  | 5.50% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Dec. 01, 2024 |  |  |
Principal Amount |  | $ 1,741 |  | $ 2,333 |  |  |
Investments at cost |  | 1,699 |  | 2,278 |  |  |
Investments at fair value |  | $ 1,604 |  | $ 2,196 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Jul. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,983 |  |  |  |  |
Investments at fair value |  | $ 4,983 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 14.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,467 |  |  |  |  |
Investments at fair value |  | $ 2,467 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.75% |  |  |  |  |
Maturity Date |  | Dec. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,946 |  |  |  |  |
Investments at fair value |  | $ 4,946 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,700 |  |  |  |  |
Investments at fair value |  | $ 3,700 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,951 |  |  |  |  |
Investments at fair value |  | $ 4,951 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.50% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,464 |  |  |  |  |
Investments at fair value |  | $ 2,464 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,475 |  |  |  |  |
Investments at fair value |  | $ 3,474 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  |  |  |  |
Margin |  | 4.75% |  |  |  |  |
Floor |  | 8.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,733 |  |  |  |  |
Investments at fair value |  | $ 3,733 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 10.75% |  |  |  |  |
Margin |  | 2.75% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,938 |  |  |  |  |
Investments at fair value |  | $ 4,938 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jan. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,696 |  |  |  |  |
Investments at fair value |  | $ 3,696 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 10,000 |  |  |  |  |
Investments at cost |  | 9,813 |  |  |  |  |
Investments at fair value |  | $ 9,411 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 8.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,479 |  |  |  |  |
Investments at fair value |  | $ 2,479 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 8.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 6.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 1,806 |  |  |  |  |
Investments at cost |  | 1,792 |  |  |  |  |
Investments at fair value |  | $ 1,678 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 1.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 4,250 |  |  |  |  |
Investments at cost |  | 4,174 |  |  |  |  |
Investments at fair value |  | $ 4,174 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.82% |  |  |  |  |
Margin |  | 4.82% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 10.36% |  |  |  |  |
Maturity Date |  | Jul. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 3,477 |  |  |  |  |
Investments at cost |  | 3,448 |  |  |  |  |
Investments at fair value |  | $ 3,448 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 4.50% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,916 |  |  |  |  |
Investments at fair value |  | $ 4,916 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Clara Foods Co [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.50% |  |  |  |  |
Maturity Date |  | Aug. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 833 |  |  |  |  |
Investments at cost |  | 828 |  |  |  |  |
Investments at fair value |  | $ 828 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 5.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 10.40% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,000 |  |  |  |  |
Investments at cost |  | 2,441 |  |  |  |  |
Investments at fair value |  | $ 2,441 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.25% |  |  |  |  |
Maturity Date |  | Oct. 31, 2023 |  |  |  |  |
Principal Amount |  | $ 2,363 |  |  |  |  |
Investments at cost |  | 2,196 |  |  |  |  |
Investments at fair value |  | $ 1,303 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.25% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 1,875 |  |  |  |  |
Investments at cost |  | 1,800 |  |  |  |  |
Investments at fair value |  | $ 1,800 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Jun. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,421 |  |  |  |  |
Investments at fair value |  | $ 2,421 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.75% |  |  |  |  |
Margin |  | 7.75% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 0.00% |  |  |  |  |
Maturity Date |  | May 01, 2027 |  |  |  |  |
Principal Amount |  | $ 680 |  |  |  |  |
Investments at cost |  | 543 |  |  |  |  |
Investments at fair value |  | $ 114 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 13.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 3,958 |  | $ 5,000 |  |  |
Investments at cost |  | 3,948 |  | 4,979 |  |  |
Investments at fair value |  | $ 3,948 |  | $ 4,979 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.72% |  | 13.22% |  |  |
Margin |  | 4.72% |  | 4.72% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | May 01, 2026 |  | Jun. 01, 2024 |  |  |
Principal Amount |  | $ 5,000 |  | $ 1,414 |  |  |
Investments at cost |  | 4,975 |  | 1,410 |  |  |
Investments at fair value |  | $ 4,975 |  | $ 1,410 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  | 13.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2027 |  | May 01, 2027 |  |  |
Principal Amount |  | $ 6,250 |  | $ 6,250 |  |  |
Investments at cost |  | 6,215 |  | 6,199 |  |  |
Investments at fair value |  | $ 6,215 |  | $ 6,199 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 13.75% |  |  |
Margin |  | 5.25% |  | 5.25% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Nov. 01, 2026 |  | Nov. 01, 2026 |  |  |
Principal Amount |  | $ 2,167 |  | $ 2,500 |  |  |
Investments at cost |  | 2,156 |  | 2,478 |  |  |
Investments at fair value |  | $ 2,156 |  | $ 2,478 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  | 14.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2025 |  | Jul. 01, 2025 |  |  |
Principal Amount |  | $ 833 |  | $ 1,500 |  |  |
Investments at cost |  | 812 |  | 1,458 |  |  |
Investments at fair value |  | $ 812 |  | $ 1,436 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  | 14.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.75% |  | 3.75% |  |  |
Maturity Date |  | Sep. 01, 2026 |  | Sep. 01, 2026 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,731 |  | 3,717 |  |  |
Investments at fair value |  | $ 3,731 |  | $ 3,717 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.36% |  | 13.86% |  |  |
Margin |  | 5.36% |  | 5.36% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.30% |  | 5.50% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Dec. 01, 2024 |  |  |
Principal Amount |  | $ 3,482 |  | $ 4,666 |  |  |
Investments at cost |  | 3,410 |  | 4,579 |  |  |
Investments at fair value |  | $ 3,218 |  | $ 4,414 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 14.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 8.75% |  | 8.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 6.00% |  | 6.00% |  |  |
Maturity Date |  | Oct. 01, 2025 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 1,315 |  |  |  |  |
Investments at cost |  | 1,299 |  | 2,096 |  |  |
Investments at fair value |  | $ 1,299 |  | $ 2,096 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,468 |  |  |  |  |
Investments at fair value |  | $ 2,468 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 10.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 10,000 |  |  |  |  |
Investments at cost |  | 9,946 |  |  |  |  |
Investments at fair value |  | $ 9,946 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,473 |  |  |  |  |
Investments at fair value |  | $ 3,473 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | DropOff, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.50% |  |  |  |  |
Floor |  | 9.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 6,280 |  |  |  |  |
Investments at cost |  | 6,211 |  |  |  |  |
Investments at fair value |  | $ 5,849 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,958 |  |  |  |  |
Investments at fair value |  | $ 4,958 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Lytics, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 14.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Dec. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 1,250 |  |  |  |  |
Investments at cost |  | 1,242 |  |  |  |  |
Investments at fair value |  | $ 1,242 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.75% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,940 |  |  |  |  |
Investments at fair value |  | $ 4,940 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Mirantis, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,929 |  |  |  |  |
Investments at fair value |  | $ 4,929 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | SafelyYou, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,938 |  |  |  |  |
Investments at fair value |  | $ 4,938 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Viken Detection Corporation [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 4.00% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,476 |  |  |  |  |
Investments at fair value |  | $ 2,476 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,491 |  |  |  |  |
Investments at fair value |  | $ 3,491 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 14.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,471 |  |  |  |  |
Investments at fair value |  | $ 2,471 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 4,375 |  |  |  |  |
Investments at cost |  | 4,353 |  |  |  |  |
Investments at fair value |  | $ 4,353 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 1,607 |  |  |  |  |
Investments at cost |  | 1,577 |  |  |  |  |
Investments at fair value |  | $ 1,034 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.75% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,903 |  |  |  |  |
Investments at fair value |  | $ 4,903 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.75% |  |  |  |  |
Maturity Date |  | Apr. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,469 |  |  |  |  |
Investments at fair value |  | $ 2,469 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,703 |  |  |  |  |
Investments at fair value |  | $ 3,703 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,692 |  |  |  |  |
Investments at fair value |  | $ 3,692 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,951 |  |  |  |  |
Investments at fair value |  | $ 4,951 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 4.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Feb. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,948 |  |  |  |  |
Investments at fair value |  | $ 4,948 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] | Networking Sector [Member] | Fictiv, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,938 |  |  |  |  |
Investments at fair value |  | $ 4,938 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 100.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 150 |  |  |  |  |
Investments at cost |  | 150 |  |  |  |  |
Investments at fair value |  | $ 150 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 8.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,711 |  |  |  |  |
Investments at fair value |  | $ 3,711 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.25% |  |  |  |  |
Maturity Date |  | Oct. 31, 2023 |  |  |  |  |
Principal Amount |  | $ 2,954 |  |  |  |  |
Investments at cost |  | 2,745 |  |  |  |  |
Investments at fair value |  | $ 1,628 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 13.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 2,375 |  | $ 3,000 |  |  |
Investments at cost |  | 2,369 |  | 2,987 |  |  |
Investments at fair value |  | $ 2,369 |  | $ 2,987 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.36% |  | 13.86% |  |  |
Margin |  | 5.36% |  | 5.36% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.31% |  | 5.50% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Dec. 01, 2024 |  |  |
Principal Amount |  | $ 1,741 |  | $ 2,333 |  |  |
Investments at cost |  | 1,699 |  | 2,278 |  |  |
Investments at fair value |  | $ 1,604 |  | 2,196 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.75% |  |  |  |  |
Maturity Date |  | Dec. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,473 |  |  |  |  |
Investments at fair value |  | $ 2,473 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 4,500 |  |  |  |  |
Investments at cost |  | 4,452 |  |  |  |  |
Investments at fair value |  | 4,452 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | 0 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 30,585 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Medical Device Sector [Member] | AccuVein Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 7 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 271 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Medical Device Sector [Member] | CVRx, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 76 |  |  |  |  |
Investments at fair value |  | $ 50 |  |  |  |  |
Number of Shares (in shares) |  | 47,410 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Avalo Therapeutics, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 311 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 117 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Imunon, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 64 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 19,671 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Mustang Bio, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 146 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 16,611 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 160 |  |  |  |  |
Investments at fair value |  | $ 316 |  |  |  |  |
Number of Shares (in shares) |  | 299,848 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 278 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 175,098 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 265 |  |  |  |  |
Investments at fair value |  | $ 110 |  |  |  |  |
Number of Shares (in shares) |  | 318,181 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Biotechnology Sector [Member] | Xeris Pharmaceuticals, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 73 |  |  |  |  |
Investments at fair value |  | $ 64 |  |  |  |  |
Number of Shares (in shares) |  | 126,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Life Science Segment [Member] | Spineology, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 143 |  |  |  |  |
Investments at fair value |  | $ 108 |  |  |  |  |
Number of Shares (in shares) |  | 2,714,033 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Axiom Space, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 46 |  |  |  |  |
Investments at fair value |  | $ 57 |  |  |  |  |
Number of Shares (in shares) |  | 1,991 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | DropOff, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 455 |  |  |  |  |
Investments at fair value |  | $ 90 |  |  |  |  |
Number of Shares (in shares) |  | 516,732 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Havenly, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 3,178 |  |  |  |  |
Investments at fair value |  | $ 2,489 |  |  |  |  |
Number of Shares (in shares) |  | 1,446,429 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 79 |  |  |  |  |
Investments at fair value |  | $ 55 |  |  |  |  |
Number of Shares (in shares) |  | 9,801 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 188 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 12,618 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Mirantis, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 223 |  |  |  |  |
Investments at fair value |  | $ 240 |  |  |  |  |
Number of Shares (in shares) |  | 948,275 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Fictiv, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 59 |  |  |  |  |
Investments at fair value |  | $ 74 |  |  |  |  |
Number of Shares (in shares) |  | 126,841 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | Halio, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 1,585 |  |  |  |  |
Investments at fair value |  | $ 2,700 |  |  |  |  |
Number of Shares (in shares) |  | 38,241,466 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Technology Sector [Member] | E La Carte, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 60 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 147,361 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 71 |  |  |  |  |
Investments at fair value |  | $ 15 |  |  |  |  |
Number of Shares (in shares) |  | 32,244 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 20 |  |  |  |  |
Investments at fair value |  | $ 19 |  |  |  |  |
Number of Shares (in shares) |  | 65 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 152 |  |  |  |  |
Investments at fair value |  | $ 131 |  |  |  |  |
Number of Shares (in shares) |  | 93,336 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 147 |  |  |  |  |
Investments at fair value |  | $ 192 |  |  |  |  |
Number of Shares (in shares) |  | 231,050 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 162 |  |  |  |  |
Investments at fair value |  | $ 13 |  |  |  |  |
Number of Shares (in shares) |  | 4,635,992 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 256 |  |  |  |  |
Investments at fair value |  | $ 197 |  |  |  |  |
Number of Shares (in shares) |  | 9,313,541 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 231 |  |  |  |  |
Investments at fair value |  | $ 169 |  |  |  |  |
Number of Shares (in shares) |  | 5,361,130 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Aerin Medical, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 66 |  |  |  |  |
Investments at fair value |  | $ 1,048 |  |  |  |  |
Number of Shares (in shares) |  | 1,818,183 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 48 |  |  |  |  |
Investments at fair value |  | $ 9 |  |  |  |  |
Number of Shares (in shares) |  | 8,800 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | Canary Medical Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 87 |  |  |  |  |
Investments at fair value |  | $ 171 |  |  |  |  |
Number of Shares (in shares) |  | 12,153 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 174 |  |  |  |  |
Investments at fair value |  | $ 471 |  |  |  |  |
Number of Shares (in shares) |  | 4,917,794 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 214 |  |  |  |  |
Investments at fair value |  | $ 169 |  |  |  |  |
Number of Shares (in shares) |  | 7,404 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 176 |  |  |  |  |
Investments at fair value |  | $ 127 |  |  |  |  |
Number of Shares (in shares) |  | 110,402 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 49 |  |  |  |  |
Investments at fair value |  | $ 53 |  |  |  |  |
Number of Shares (in shares) |  | 48,076 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 64 |  |  |  |  |
Investments at fair value |  | $ 58 |  |  |  |  |
Number of Shares (in shares) |  | 103,679 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 312 |  |  |  |  |
Investments at fair value |  | $ 222 |  |  |  |  |
Number of Shares (in shares) |  | 709,981 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 195 |  |  |  |  |
Investments at fair value |  | $ 167 |  |  |  |  |
Number of Shares (in shares) |  | 1,600,002 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 71 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 135,484 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Magnolia Medical Technologies, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 194 |  |  |  |  |
Investments at fair value |  | $ 304 |  |  |  |  |
Number of Shares (in shares) |  | 809,931 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Meditrina, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 83 |  |  |  |  |
Investments at fair value |  | $ 29 |  |  |  |  |
Number of Shares (in shares) |  | 233,993 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Scientia Vascular, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 103 |  |  |  |  |
Investments at fair value |  | $ 273 |  |  |  |  |
Number of Shares (in shares) |  | 34,410 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | MicroTransponder, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 48 |  |  |  |  |
Investments at fair value |  | $ 48 |  |  |  |  |
Number of Shares (in shares) |  | 103,172 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | VERO Biotech LLC [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 432 |  |  |  |  |
Investments at fair value |  | $ 196 |  |  |  |  |
Number of Shares (in shares) |  | 4,109 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Sonex Health, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 275 |  |  |  |  |
Investments at fair value |  | $ 262 |  |  |  |  |
Number of Shares (in shares) |  | 2,637,133 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Life Science Segment [Member] | Spineology, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 16 |  |  |  |  |
Investments at fair value |  | $ 27 |  |  |  |  |
Number of Shares (in shares) |  | 2,255,155 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Clara Foods Co [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 30 |  |  |  |  |
Investments at fair value |  | $ 121 |  |  |  |  |
Number of Shares (in shares) |  | 46,745 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Kodiak Robotics, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 273 |  |  |  |  |
Investments at fair value |  | $ 9 |  |  |  |  |
Number of Shares (in shares) |  | 639,918 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Noodle Partners, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 116 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 84,037 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Reputation Institute, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 63 |  |  |  |  |
Investments at fair value |  | $ 33 |  |  |  |  |
Number of Shares (in shares) |  | 4,104 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Revinate Holdings, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 44 |  |  |  |  |
Investments at fair value |  | $ 90 |  |  |  |  |
Number of Shares (in shares) |  | 682,034 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | CAMP NYC, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 36 |  |  |  |  |
Investments at fair value |  | $ 39 |  |  |  |  |
Number of Shares (in shares) |  | 112,356 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Lytics, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 43 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 85,543 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | SIGNiX, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 225 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 186,235 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Slingshot Aerospace, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 123 |  |  |  |  |
Investments at fair value |  | $ 79 |  |  |  |  |
Number of Shares (in shares) |  | 309,208 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Supply Network Visiblity Holdings LLC [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 65 |  |  |  |  |
Investments at fair value |  | $ 75 |  |  |  |  |
Number of Shares (in shares) |  | 682 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 454 |  |  |  |  |
Investments at fair value |  | $ 622 |  |  |  |  |
Number of Shares (in shares) |  | 53,264 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 9 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 3,913,723 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Topia Mobility, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 137 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 3,049,607 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Viken Detection Corporation [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 120 |  |  |  |  |
Investments at fair value |  | $ 203 |  |  |  |  |
Number of Shares (in shares) |  | 345,443 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | xAd, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 176 |  |  |  |  |
Investments at fair value |  | $ 7 |  |  |  |  |
Number of Shares (in shares) |  | 4,343,348 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Lemongrass Holdings, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 34 |  |  |  |  |
Investments at fair value |  | $ 83 |  |  |  |  |
Number of Shares (in shares) |  | 101,308 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Intelepeer Holdings, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 137 |  |  |  |  |
Investments at fair value |  | $ 2,100 |  |  |  |  |
Number of Shares (in shares) |  | 2,936,535 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Alula Holdings, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 93 |  |  |  |  |
Investments at fair value |  | $ 7 |  |  |  |  |
Number of Shares (in shares) |  | 20,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Optoro, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 181 |  |  |  |  |
Investments at fair value |  | $ 144 |  |  |  |  |
Number of Shares (in shares) |  | 11,550 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Standvast Holdings, LLC [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 275 |  |  |  |  |
Investments at fair value |  | $ 258 |  |  |  |  |
Number of Shares (in shares) |  | 1,225,492 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Unagi, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 29 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 171,081 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | MyForest Foods Co [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 28 |  |  |  |  |
Investments at fair value |  | $ 24 |  |  |  |  |
Number of Shares (in shares) |  | 250 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Primary Kids, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 57 |  |  |  |  |
Investments at fair value |  | $ 587 |  |  |  |  |
Number of Shares (in shares) |  | 553,778 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Britecore Holdings, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 98 |  |  |  |  |
Investments at fair value |  | $ 254 |  |  |  |  |
Number of Shares (in shares) |  | 161,215 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Quip NYC Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 325 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 6,191 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Lotame Solutions, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 18 |  |  |  |  |
Investments at fair value |  | $ 40 |  |  |  |  |
Number of Shares (in shares) |  | 71,305 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Updater, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 34 |  |  |  |  |
Investments at fair value |  | $ 26 |  |  |  |  |
Number of Shares (in shares) |  | 108,333 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | CPG Beyond, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 242 |  |  |  |  |
Investments at fair value |  | $ 290 |  |  |  |  |
Number of Shares (in shares) |  | 500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Silk, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 175 |  |  |  |  |
Investments at fair value |  | $ 119 |  |  |  |  |
Number of Shares (in shares) |  | 394,110 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Global Worldwide LLC [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 75 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 245,810 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Rocket Lawyer Incorporated [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 92 |  |  |  |  |
Investments at fair value |  | $ 313 |  |  |  |  |
Number of Shares (in shares) |  | 261,721 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Skillshare, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 162 |  |  |  |  |
Investments at fair value |  | $ 671 |  |  |  |  |
Number of Shares (in shares) |  | 139,074 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Liqid, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 364 |  |  |  |  |
Investments at fair value |  | $ 103 |  |  |  |  |
Number of Shares (in shares) |  | 344,102 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Avalanche Technology, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 45 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 5,938 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Technology Sector [Member] | Everstream Holdings, LLC [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 70 |  |  |  |  |
Investments at fair value |  | $ 21 |  |  |  |  |
Number of Shares (in shares) |  | 350,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | BrightInsight, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 167 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 85,066 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Hound Labs, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 45 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 451,796 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 166 |  |  |  |  |
Investments at fair value |  | $ 47 |  |  |  |  |
Number of Shares (in shares) |  | 184,253 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Elligo Healthcare Research, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 191 |  |  |  |  |
Investments at fair value |  | $ 85 |  |  |  |  |
Number of Shares (in shares) |  | 652,250 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Kate Farms, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 103 |  |  |  |  |
Investments at fair value |  | $ 777 |  |  |  |  |
Number of Shares (in shares) |  | 82,965 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | Medsphere Systems Corporation [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 61 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 7,097,792 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | SafelyYou, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 163 |  |  |  |  |
Investments at fair value |  | $ 11 |  |  |  |  |
Number of Shares (in shares) |  | 150,353 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Healthcare Information and Services Segment [Member] | GT Medical Technologies, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 85 |  |  |  |  |
Investments at fair value |  | $ 86 |  |  |  |  |
Number of Shares (in shares) |  | 255,871 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 82 |  |  |  |  |
Investments at fair value |  | $ 69 |  |  |  |  |
Number of Shares (in shares) |  | 400,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | LiquiGlide, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 40 |  |  |  |  |
Investments at fair value |  | $ 25 |  |  |  |  |
Number of Shares (in shares) |  | 61,359 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 382 |  |  |  |  |
Investments at fair value |  | $ 489 |  |  |  |  |
Number of Shares (in shares) |  | 1,103 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | Temperpack Technologies, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 178 |  |  |  |  |
Investments at fair value |  | $ 91 |  |  |  |  |
Number of Shares (in shares) |  | 49,693 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] | Sustainability Segment [Member] | Pivot Bio, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 14 |  |  |  |  |
Investments at fair value |  | $ 14 |  |  |  |  |
Number of Shares (in shares) |  | 210,418 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 8,886 |  | 6,132 |  |  |
Investments at fair value |  | $ 7,488 |  | $ 4,733 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.50% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,464 |  |  |  |  |
Investments at fair value |  | $ 2,464 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,469 |  |  |  |  |
Investments at fair value |  | $ 3,468 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,959 |  |  |  |  |
Investments at fair value |  | $ 4,959 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 10.75% |  |  |  |  |
Margin |  | 2.75% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 4,000 |  |  |  |  |
Investments at cost |  | 3,950 |  |  |  |  |
Investments at fair value |  | $ 3,950 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,907 |  |  |  |  |
Investments at fair value |  | $ 4,706 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 8.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,957 |  |  |  |  |
Investments at fair value |  | $ 4,957 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 1.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 4,250 |  |  |  |  |
Investments at cost |  | 4,174 |  |  |  |  |
Investments at fair value |  | $ 4,174 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 4.50% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,916 |  |  |  |  |
Investments at fair value |  | $ 4,916 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.50% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 10.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 7.78% |  |  |  |  |
Maturity Date |  | Feb. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,813 |  |  |  |  |
Investments at cost |  | 2,813 |  |  |  |  |
Investments at fair value |  | $ 2,813 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.25% |  |  |  |  |
Maturity Date |  | Oct. 31, 2023 |  |  |  |  |
Principal Amount |  | $ 2,954 |  |  |  |  |
Investments at cost |  | 2,745 |  |  |  |  |
Investments at fair value |  | $ 1,628 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.75% |  |  |  |  |
Margin |  | 7.75% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 0.00% |  |  |  |  |
Maturity Date |  | May 01, 2027 |  |  |  |  |
Principal Amount |  | $ 680 |  |  |  |  |
Investments at cost |  | 543 |  |  |  |  |
Investments at fair value |  | $ 114 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 13.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 2,375 |  | $ 3,000 |  |  |
Investments at cost |  | 2,368 |  | 2,987 |  |  |
Investments at fair value |  | $ 2,368 |  | $ 2,987 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.22% |  |  |
Margin |  |  |  | 4.72% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Nov. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,950 |  |  |
Investments at fair value |  |  |  | $ 4,950 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  | 14.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.75% |  | 3.75% |  |  |
Maturity Date |  | Sep. 01, 2026 |  | Sep. 01, 2026 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,731 |  | 3,717 |  |  |
Investments at fair value |  | $ 3,731 |  | $ 3,717 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.36% |  | 13.86% |  |  |
Margin |  | 5.36% |  | 5.36% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.31% |  | 5.50% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Dec. 01, 2024 |  |  |
Principal Amount |  | $ 1,741 |  | $ 2,333 |  |  |
Investments at cost |  | 1,701 |  | 2,281 |  |  |
Investments at fair value |  | $ 1,605 |  | 2,199 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 10.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,973 |  |  |  |  |
Investments at fair value |  | $ 4,973 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,473 |  |  |  |  |
Investments at fair value |  | $ 3,473 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | DropOff, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.50% |  |  |  |  |
Floor |  | 9.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 2,617 |  |  |  |  |
Investments at cost |  | 2,590 |  |  |  |  |
Investments at fair value |  | $ 2,439 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,958 |  |  |  |  |
Investments at fair value |  | $ 4,958 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Lytics, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 14.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 1,000 |  |  |  |  |
Investments at cost |  | 996 |  |  |  |  |
Investments at fair value |  | $ 996 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.75% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,940 |  |  |  |  |
Investments at fair value |  | $ 4,940 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Mirantis, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,929 |  |  |  |  |
Investments at fair value |  | $ 4,929 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Viken Detection Corporation [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 4.00% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,476 |  |  |  |  |
Investments at fair value |  | $ 2,476 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,493 |  |  |  |  |
Investments at fair value |  | $ 2,493 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 14.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,471 |  |  |  |  |
Investments at fair value |  | $ 2,471 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 4,375 |  |  |  |  |
Investments at cost |  | 4,353 |  |  |  |  |
Investments at fair value |  | $ 4,353 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 3,214 |  |  |  |  |
Investments at cost |  | 3,151 |  |  |  |  |
Investments at fair value |  | $ 2,068 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.33% |  |  |  |  |
Maturity Date |  | Dec. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,712 |  |  |  |  |
Investments at fair value |  | $ 3,712 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.75% |  |  |  |  |
Maturity Date |  | May 01, 2026 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,938 |  |  |  |  |
Investments at fair value |  | $ 4,938 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 7,500 |  |  |  |  |
Investments at cost |  | 7,400 |  |  |  |  |
Investments at fair value |  | $ 7,400 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 7,500 |  |  |  |  |
Investments at cost |  | 7,384 |  |  |  |  |
Investments at fair value |  | $ 7,384 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,951 |  |  |  |  |
Investments at fair value |  | $ 4,951 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 0.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 200 |  |  |  |  |
Investments at cost |  | 200 |  |  |  |  |
Investments at fair value |  | $ 200 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 8.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,711 |  |  |  |  |
Investments at fair value |  | $ 3,711 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.25% |  |  |  |  |
Maturity Date |  | Oct. 31, 2023 |  |  |  |  |
Principal Amount |  | $ 5,908 |  |  |  |  |
Investments at cost |  | 5,489 |  |  |  |  |
Investments at fair value |  | $ 3,255 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 2,000 |  |  |  |  |
Investments at cost |  | 1,979 |  |  |  |  |
Investments at fair value |  | 1,979 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 17,167 |  | 16,400 |  |  |
Investments at fair value |  | 18,735 |  | 24,594 |  |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Life Science Segment [Member] |  |  |  |  |  |  |
Investments at cost |  | 5,078 |  | 4,702 |  |  |
Investments at fair value |  | 4,984 |  | 7,675 |  |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Technology Sector [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 9,733 |  |  |
Investments at fair value |  |  |  | 14,506 |  |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Other Sustainability Sector [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 999 |  |  |
Investments at fair value |  |  |  | $ 542 |  |  |
Number of Shares (in shares) |  |  |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Healthcare Information and Services Segment [Member] |  |  |  |  |  |  |
Investments at cost |  | 1,052 |  | $ 966 |  |  |
Investments at fair value |  | 1,021 |  | $ 1,871 |  |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] | Sustainability Segment [Member] |  |  |  |  |  |  |
Investments at cost |  | 716 |  |  |  |  |
Investments at fair value |  | $ 707 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,469 |  |  |  |  |
Investments at fair value |  | $ 3,468 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,927 |  |  |  |  |
Investments at fair value |  | $ 4,927 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,453 |  |  |  |  |
Investments at fair value |  | $ 2,353 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 8.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,957 |  |  |  |  |
Investments at fair value |  | $ 4,957 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.00% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 1.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,455 |  |  |  |  |
Investments at fair value |  | $ 2,455 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.50% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 10.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 7.78% |  |  |  |  |
Maturity Date |  | Feb. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,813 |  |  |  |  |
Investments at cost |  | 2,813 |  |  |  |  |
Investments at fair value |  | $ 2,813 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.25% |  |  |  |  |
Maturity Date |  | Oct. 31, 2023 |  |  |  |  |
Principal Amount |  | $ 3,545 |  |  |  |  |
Investments at cost |  | 3,294 |  |  |  |  |
Investments at fair value |  | $ 1,953 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 13.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 3,958 |  | $ 5,000 |  |  |
Investments at cost |  | 3,948 |  | 4,979 |  |  |
Investments at fair value |  | $ 3,948 |  | $ 4,979 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.22% |  |  |
Margin |  |  |  | 4.72% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | May 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,949 |  |  |
Investments at fair value |  |  |  | $ 4,949 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.36% |  | 13.86% |  |  |
Margin |  | 5.36% |  | 5.36% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.31% |  | 5.50% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Dec. 01, 2024 |  |  |
Principal Amount |  | $ 1,741 |  | $ 2,333 |  |  |
Investments at cost |  | 1,701 |  | 2,281 |  |  |
Investments at fair value |  | $ 1,605 |  | 2,199 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 10.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,973 |  |  |  |  |
Investments at fair value |  | $ 4,973 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,750 |  |  |  |  |
Investments at cost |  | 2,717 |  |  |  |  |
Investments at fair value |  | $ 2,717 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.75% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,940 |  |  |  |  |
Investments at fair value |  | $ 4,940 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Mirantis, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,929 |  |  |  |  |
Investments at fair value |  | $ 4,929 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 1,500 |  |  |  |  |
Investments at cost |  | 1,496 |  |  |  |  |
Investments at fair value |  | $ 1,496 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 14.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,471 |  |  |  |  |
Investments at fair value |  | $ 2,471 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.75% |  |  |  |  |
Maturity Date |  | May 01, 2026 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,469 |  |  |  |  |
Investments at fair value |  | $ 2,469 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,700 |  |  |  |  |
Investments at fair value |  | $ 3,700 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,951 |  |  |  |  |
Investments at fair value |  | 4,951 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Axiom Space, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | 261 |  |  |  |  |
Investments at fair value |  | $ 306 |  |  |  |  |
Number of Shares (in shares) |  | 1,810 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 89 |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Number of Shares (in shares) |  | 2,688,971 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | PebblePost, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 73 |  |  |  |  |
Investments at fair value |  | $ 73 |  |  |  |  |
Number of Shares (in shares) |  | 598,850 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Caastle, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 2,681 |  |  |  |  |
Investments at fair value |  | $ 2,687 |  |  |  |  |
Number of Shares (in shares) |  | 242,180 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Decisyon, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 2,800 |  |  |  |  |
Investments at fair value |  | $ 1,281 |  |  |  |  |
Number of Shares (in shares) |  | 280,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Lotame Solutions, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 5 |  |  |  |  |
Investments at fair value |  | $ 190 |  |  |  |  |
Number of Shares (in shares) |  | 66,127 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 89 |  |  |
Investments at fair value |  |  |  | $ 89 |  |  |
Number of Shares (in shares) |  |  |  | 2,688,971 |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Software Sector [Member] | Decisyon, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 2,800 |  |  |
Investments at fair value |  |  |  | $ 1,281 |  |  |
Number of Shares (in shares) |  |  |  | 280,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Software Sector [Member] | Lotame Solutions, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 4 |  |  |
Investments at fair value |  |  |  | $ 193 |  |  |
Number of Shares (in shares) |  |  |  | 66,127 |  |  |
Investment, Unaffiliated Issuer [Member] | Preferred Stock [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 261 |  |  |
Investments at fair value |  |  |  | $ 306 |  |  |
Number of Shares (in shares) |  |  |  | 1,810 |  |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 645,930 |  | $ 692,345 |  |  |
Investments at fair value |  | 626,392 |  | 664,203 |  |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Life Science Segment [Member] |  |  |  |  |  |  |
Investments at cost |  | 263,158 |  |  |  |  |
Investments at fair value |  | 260,177 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Technology Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 208,250 |  | 275,026 |  |  |
Investments at fair value |  | 194,051 |  | 269,790 |  |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Life Science [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 249,642 |  |  |
Investments at fair value |  |  |  | 244,815 |  |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Healthcare Information and Services Segment [Member] |  |  |  |  |  |  |
Investments at cost |  | 106,542 |  | 69,770 |  |  |
Investments at fair value |  | 104,184 |  | 69,770 |  |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] | Sustainability Segment [Member] |  |  |  |  |  |  |
Investments at cost |  | 67,980 |  | 97,907 |  |  |
Investments at fair value |  | $ 67,980 |  | 79,828 |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 0.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 350 |  |  |  |  |
Investments at cost |  | 350 |  |  |  |  |
Investments at fair value |  | $ 350 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 8.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,711 |  |  |  |  |
Investments at fair value |  | $ 3,711 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  |  |  |  |
Margin |  | 5.75% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.25% |  |  |  |  |
Maturity Date |  | Oct. 31, 2023 |  |  |  |  |
Principal Amount |  | $ 2,954 |  |  |  |  |
Investments at cost |  | 2,745 |  |  |  |  |
Investments at fair value |  | 1,628 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Other Investments [Member] |  |  |  |  |  |  |
Investments at cost |  | 8,418 |  |  |  |  |
Investments at fair value |  | 3,347 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Other Investments [Member] | Life Science [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 1,200 |  |  |
Investments at fair value |  |  |  | $ 200 |  |  |
Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] | Life Science Segment [Member] | Robin Healthcare, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | 7,271 |  |  |  |  |
Investments at fair value |  | 3,247 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] | Life Science Segment [Member] | Lumithera, Inc. [Member] |  |  |  |  |  |  |
Investments at cost |  | 1,147 |  |  |  |  |
Investments at fair value |  | 100 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] | Life Science Segment [Member] | ZetrOZ, Inc [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  |  |  |  |
Investments at fair value |  |  |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index One [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 9.00% |  |  |  |  |
Margin |  | 0.00% |  |  |  |  |
Floor |  | 0.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 18.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,477 |  |  |  |  |
Investments at fair value |  | $ 2,205 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index One [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 0.00% |  |  |  |  |
Floor |  | 0.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 50.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 300 |  |  |  |  |
Investments at cost |  | 300 |  |  |  |  |
Investments at fair value |  | $ 197 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index Two [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 9.00% |  |  |  |  |
Margin |  | 0.00% |  |  |  |  |
Floor |  | 0.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 18.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,477 |  |  |  |  |
Investments at fair value |  | $ 2,205 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index Two [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 0.00% |  |  |  |  |
Floor |  | 0.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 100.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 250 |  |  |  |  |
Investments at cost |  | 250 |  |  |  |  |
Investments at fair value |  | $ 164 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index Three [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] |  |  |  |  |  |  |
Cash Rate |  | 9.00% |  |  |  |  |
Margin |  | 0.00% |  |  |  |  |
Floor |  | 0.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 18.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 200 |  |  |  |  |
Investments at cost |  | 188 |  |  |  |  |
Investments at fair value |  | $ 168 |  |  |  |  |
[1] | As of September 30, 2023, the Company no longer owns 5% or more of the portfolio company.

X
- Definition The ceiling rate of the investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedCeilingRate
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The end of term payment rate (ETP) on investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maturity date of investment, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-2 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_EnergyEfficiencyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DataStorageSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_InternetAndMediaSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_PowerManagementSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SemiconductorSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareHealthcareInformationAndServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_UnrestrictedShortTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_USBankMoneyMarketDepositAccountMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_RestrictedShortTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AuleaMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerControlledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HIMVLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CandesantBiomedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MicroTransponderIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ZetrozIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CVRXIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexElevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AterianIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CZVIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TallacTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ReputationInstituteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_Engage3LLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MirantisIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ParseBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NewAerofarmsIncAssigneeOfAerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwelveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CPGBeyondIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HalioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StandvastHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthcareResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GTMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HometeamTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PivotBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_FictivIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_HealthcareInformationAndServicesSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |